{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-000143","form_type":"8-K","ticker":"CDT","cik":"0001896212","company_name":"CDT Equity Inc.","filed_at":"2026-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.704764+00:00","generated_at":"2026-05-16T11:51:02.535706+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"CDT enters consulting pacts with Thesprogen and NJS; issues 213,288 shares for $305k in services","bullets":["Thesprogen will evaluate AZD1656 pre-clinical data and optimize development strategies; 6-month term, $155k fee paid in 108,392 shares.","NJS to identify out-licensing partners for solid-form patent portfolio; $150k retainer in 104,896 shares plus 8% commission on transactions.","Shares issued in unregistered transaction under Regulation D; no registration rights granted.","Press release highlights NJS engagement to accelerate licensing and royalty-based deals for solid-form assets."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-000143","json":"https://secwatch.observer/filing/0001493152-26-000143.json","markdown":"https://secwatch.observer/filing/0001493152-26-000143.md","text":"https://secwatch.observer/filing/0001493152-26-000143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:51:02.535706+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"65c7ef4361a483c545ae93fb9f368e593635e29b","claim":"CDT Equity Inc. entered into Thesprogen Agreement with Thesprogen, PC valued at $155,000 of consideration (effective 2025-12-28).","evidence_excerpt":"On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","confidence":0.9},{"claim_id":"7967154b808bcc100b3e113e029d19154f2a3b80","claim":"CDT Equity Inc. entered into NJS Agreement with NJS Foresight Bio-Advisory, LLC valued at one-time fixed retainer of $150,000 (effective 2025-12-29).","evidence_excerpt":"On December 29, 2025 (the “Effective Date”) the Company and NJS Foresight Bio-Advisory, LLC (“NJS”) entered into a Consulting Agreement (the “NJS Agreement,” together with the Thesprogen Agreement, the “Agreements”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001437749-26-015613","ticker":"GOVX","company_name":"GeoVax Labs, Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"GeoVax raises ~$595k via warrant inducement; issues new warrants for 1M shares at $1.65","event_type":"other_material","sec_items":["1.01","3.02","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 3.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-015613","json":"https://secwatch.observer/filing/0001437749-26-015613.json","markdown":"https://secwatch.observer/filing/0001437749-26-015613.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774926015613/0001437749-26-015613-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774926015613/govx20260507_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","comparable_excerpt":"On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926015613/0001437749-26-015613-index.htm"}},{"accession":"0000790816-26-000019","ticker":null,"company_name":"BRANDYWINE OPERATING PARTNERSHIP, L.P.","filed_at":"2026-06-01T20:30:42+00:00","headline":"Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP","event_type":"other_material","sec_items":["1.01","2.03","5.02","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000790816-26-000019","json":"https://secwatch.observer/filing/0000790816-26-000019.json","markdown":"https://secwatch.observer/filing/0000790816-26-000019.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1060386/000079081626000019/0000790816-26-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/790816/000079081626000019/bdn-20260528.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","comparable_excerpt":"extended the maturity date of the Borrowers’ revolving credit facility","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1060386/000079081626000019/0000790816-26-000019-index.htm"}},{"accession":"0001539497-26-001624","ticker":null,"company_name":"BMO 2026-5C14 Mortgage Trust","filed_at":"2026-06-01T18:53:15+00:00","headline":"BMO 2026-5C14 transfers Compass Storage Whole Loan servicing to Benchmark 2026-V22","event_type":"other_material","sec_items":["1.01","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001539497-26-001624","json":"https://secwatch.observer/filing/0001539497-26-001624.json","markdown":"https://secwatch.observer/filing/0001539497-26-001624.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2063015/000153949726001624/0001539497-26-001624-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2063015/000153949726001624/n5711_x18-8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","comparable_excerpt":"On March 25, 2026 (the “ Closing Date ”), BMO 2026-5C14 Mortgage Trust (the “ Issuing Entity ”) issued the BMO 2026-5C14 Mortgage Trust, Commercial Mortgage Pass-Through Certificates, Series 2026-5C14, pursuant to a Pooling and Servicing Agreement, dated as of March 1, 2026 (the “ Pooling and Servicing Agreement ”), between BMO Commercial Mortgage Securities LLC, as depositor, Midland Loan Services, a Division of PNC Bank, National Association, as master servicer, CWCapital Asset Management LLC, as special servicer, Pentalpha Surveillance LLC, as operating advisor and as asset representations reviewer, and Computershare Trust Company, National Association, as certificate administrator and as trustee.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2063015/000153949726001624/0001539497-26-001624-index.htm"}},{"accession":"0001213900-26-054186","ticker":"SNYR","company_name":"Synergy CHC Corp.","filed_at":"2026-05-11T23:59:59+00:00","headline":"Synergy CHC enters up to $36M equity purchase agreement with Hudson Global Ventures","event_type":"other_material","sec_items":["1.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-054186","json":"https://secwatch.observer/filing/0001213900-26-054186.json","markdown":"https://secwatch.observer/filing/0001213900-26-054186.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1562733/000121390026054186/0001213900-26-054186-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1562733/000121390026054186/ea0289929-8k_synergy.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","comparable_excerpt":"On May 8, 2026, Synergy CHC Corp. (the “Company”) entered into an equity purchase agreement (the “Purchase Agreement”) with Hudson Global Ventures, LLC (the “Investor”), pursuant to which the Company has the right, but not the obligation, to direct the Investor to purchase up to $36,000,000 of the Company’s common stock","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1562733/000121390026054186/0001213900-26-054186-index.htm"}},{"accession":"0001500217-26-000035","ticker":"AAT","company_name":"American Assets Trust, Inc.","filed_at":"2026-05-11T23:59:59+00:00","headline":"AAT board raises Rady Trust ownership cap to 21.9%, lowers general limit to 6.775%","event_type":"other_material","sec_items":["1.01","3.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001500217-26-000035","json":"https://secwatch.observer/filing/0001500217-26-000035.json","markdown":"https://secwatch.observer/filing/0001500217-26-000035.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500217/000150021726000035/0001500217-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500217/000150021726000035/aat-20260511.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","comparable_excerpt":"On May 11, 2026, American Assets Trust, Inc. (the \"Company\") entered into a Voting Support Agreement (the \"Voting Agreement\") with the Ernest Rady Trust U/D/T March 10, 1983 (the \"Rady Trust\"), the Evelyn Shirley Rady Trust U/D/T March 10, 1983, and American Assets, Inc. (collectively, the \"Stockholder\").","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1500217/000150021726000035/0001500217-26-000035-index.htm"}},{"accession":"0001213900-26-053856","ticker":null,"company_name":"21Shares Polkadot ETF","filed_at":"2026-05-08T23:59:59+00:00","headline":"21Shares Polkadot ETF enters Figment staking agreement; 26.5% of rewards to service providers","event_type":"other_material","sec_items":["1.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-053856","json":"https://secwatch.observer/filing/0001213900-26-053856.json","markdown":"https://secwatch.observer/filing/0001213900-26-053856.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2054247/000121390026053856/0001213900-26-053856-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2054247/000121390026053856/ea0289774-8k_21shares.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","comparable_excerpt":"On May 4, 2026, 21Shares Polkadot ETF (the “Trust”) entered into a staking services agreement with Figment Inc., an Ontario corporation (“Figment” and such agreement, the “Figment Agreement”),","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2054247/000121390026053856/0001213900-26-053856-index.htm"}},{"accession":"0000943374-26-000191","ticker":"PBHC","company_name":"Pathfinder Bancorp, Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"Pathfinder Bancorp and Castle Creek Amend Registration Rights Agreement, Extending Filing Deadline to May 8, 2027","event_type":"other_material","sec_items":["1.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000943374-26-000191","json":"https://secwatch.observer/filing/0000943374-26-000191.json","markdown":"https://secwatch.observer/filing/0000943374-26-000191.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1609065/000094337426000191/0000943374-26-000191-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1609065/000094337426000191/form8k_050426.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","comparable_excerpt":"On May 4, 2026, the Company and Castle Creek agreed to amend the Registration Rights Agreement to allow the Company to file a resale registration statement by no later than May 8, 2027 to register the resale of the securities.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1609065/000094337426000191/0000943374-26-000191-index.htm"}},{"accession":"0001193125-26-212007","ticker":"ENB","company_name":"ENBRIDGE INC","filed_at":"2026-05-07T23:59:59+00:00","headline":"Enbridge shareholders approve directors, auditor, say-on-pay, and rights plan at AGM","event_type":"other_material","sec_items":["1.01","3.03","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-212007","json":"https://secwatch.observer/filing/0001193125-26-212007.json","markdown":"https://secwatch.observer/filing/0001193125-26-212007.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/895728/000119312526212007/0001193125-26-212007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/895728/000119312526212007/enb-20260506.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm","comparable_excerpt":"the holders of common shares of Enbridge Inc. (the “Corporation”) voted to amend, reconfirm and approve the Corporation’s shareholder rights plan (the “Rights Plan”) under the terms of an agreement between the Corporation and Computershare Trust Company of Canada (“Computershare”), as rights agent.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/895728/000119312526212007/0001193125-26-212007-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}